Sichelzellanämie (German Wikipedia)

Analysis of information sources in references of the Wikipedia article "Sichelzellanämie" in German language version.

refsWebsite

Global rank German rank

15doi.org

2^nd place

3^rd place

12nih.gov

4^th place

7^th place

1spektrum.de

1,960^th place

130^th place

1roteskreuz.at

low place

6,228^th place

1deadurl.invalid

low place

1mementoweb.org

317^th place

14^th place

1labor28.de

low place

1labor-lademannbogen.de

low place

1rki.de

4,845^th place

310^th place

1web.archive.org

1^st place

1nature.com

234^th place

203^rd place

1scinexx.de

7,917^th place

477^th place

1fda.gov

447^th place

751^st place

deadurl.invalid

Prof. R. Heinz: Transfusionsmedizin und Migration@1@2Vorlage:Toter Link/www.roteskreuz.at (Seite nicht mehr abrufbar, festgestellt im Mai 2024. Suche in Webarchiven)

doi.org

V. R. Mason: Sickle Cell Anemia. In: The Journal of the American Medical Association. Band 79, 1922, S. 1318–1320, doi:10.1001/jama.254.14.1955 (Reprint).
K. Sun, Y. Xia: New insights into sickle cell disease: a disease of hypoxia. In: Current Opinion in Hematology. Band 20, Nummer 3, Mai 2013, S. 215–221. doi:10.1097/MOH.0b013e32835f55f9. PMID 23549375.
E. Sparkenbaugh, R. Pawlinski: Interplay between coagulation and vascular inflammation in sickle cell disease. In: British Journal of Haematology. Band 162, Nummer 1, Juli 2013, S. 3–14. doi:10.1111/bjh.12336. PMC 3878906 (freier Volltext).
B. E. Gee: Biologic complexity in sickle cell disease: implications for developing targeted therapeutics. In: TheScientificWorldJournal. 2013, S. 694146. doi:10.1155/2013/694146. PMC 3621302 (freier Volltext).
M. Y. Lim, K. I. Ataga, N. S. Key: Hemostatic abnormalities in sickle cell disease. In: Current Opinion in Hematology. Band 20, Nummer 5, September 2013, S. 472–477. doi:10.1097/MOH.0b013e328363442f. PMID 23817169.
S. Sheth, M. Licursi, M. Bhatia: Sickle cell disease: time for a closer look at treatment options? In: British Journal of Haematology. Band 162, Nummer 4, August 2013, S. 455–464. doi:10.1111/bjh.12413
Raimund Hirschberg: Glomerular hyperfiltration in sickle cell disease. In: Clinical Journal of the American Society of Nephrology. Band 5, Nr. 5, Mai 2010, S. 748–749, doi:10.2215/CJN.01340210.
T. N. Williams, S. K. Obaro: Sickle cell disease and malaria morbidity: a tale with two tails. In: Trends in Parasitology. Band 27, Nummer 7, Juli 2011, S. 315–320. doi:10.1016/j.pt.2011.02.004
Joachim B. Kunz, Stephan Lobitz, Regine Grosse, Lena Oevermann, Dani Hakimeh: Sickle cell disease in Germany: Results from a national registry. In: Pediatric Blood & Cancer. Band 67, Nr. 4, 2020, S. e28130, doi:10.1002/pbc.28130.
I. Akinsheye, A. Alsultan, N. Solovieff, D. Ngo, C. T. Baldwin, P. Sebastiani, D. H. Chui, M. H. Steinberg: Fetal hemoglobin in sickle cell anemia. In: Blood. Band 118, Nummer 1, Juli 2011, S. 19–27. doi:10.1182/blood-2011-03-325258. PMID 21490337. PMC 3139383 (freier Volltext).
O S Platt, S H Orkin, G Dover, G P Beardsley, B Miller: Hydroxyurea enhances fetal hemoglobin production in sickle cell anemia. In: Journal of Clinical Investigation. Band 74, Nr. 2, 1984, S. 652–656, doi:10.1172/JCI111464, PMC 370519 (freier Volltext).
Winfred C Wang, Russell E Ware, Scott T Miller, Rathi V Iyer, James F Casella: Hydroxycarbamide in very young children with sickle-cell anaemia: a multicentre, randomised, controlled trial (BABY HUG). In: The Lancet. Band 377, Nr. 9778, 14. Mai 2011, S. 1663–1672, doi:10.1016/S0140-6736(11)60355-3, PMC 3133619 (freier Volltext).
Ersi Voskaridou, Dimitrios Christoulas, Antonios Bilalis, Eleni Plata, Konstantinos Varvagiannis: The effect of prolonged administration of hydroxyurea on morbidity and mortality in adult patients with sickle cell syndromes: results of a 17-year, single-center trial (LaSHS). In: Blood. Band 115, Nr. 12, 25. März 2010, S. 2354–2363, doi:10.1182/blood-2009-05-221333.
Léon Tshilolo, George Tomlinson, Thomas N Williams, Brígida Santos, Peter Olupot-Olupot: Hydroxyurea for Children with Sickle Cell Anemia in Sub-Saharan Africa. In: New England Journal of Medicine. Band 380, Nr. 2, 10. Januar 2019, S. 121–131, doi:10.1056/NEJMoa1813598.
C. Oringanje, E. Nemecek, O. Oniyangi: Hematopoietic stem cell transplantation for people with sickle cell disease. In: The Cochrane database of systematic reviews. Band 5, 2013, S. CD007001. doi:10.1002/14651858.CD007001.pub3

fda.gov

FDA Approves First Gene Therapies to Treat Patients with Sickle Cell Disease https://www.fda.gov/news-events/press-announcements/fda-approves-first-gene-therapies-treat-patients-sickle-cell-disease

labor-lademannbogen.de

Sichelzellanämie – HBB – Humangenetik – Analysen-Spektrum – Labor Lademannbogen. Abgerufen am 10. April 2020.

labor28.de

Lukas Wagner: Hämoglobin E – Strukturvariante mit β-Thalassämiecharakter. MVZ Labor 28, abgerufen am 19. Oktober 2020.

mementoweb.org

timetravel.mementoweb.org

Prof. R. Heinz: Transfusionsmedizin und Migration@1@2Vorlage:Toter Link/www.roteskreuz.at (Seite nicht mehr abrufbar, festgestellt im Mai 2024. Suche in Webarchiven)

nature.com

nature.com

nih.gov

ncbi.nlm.nih.gov

J. B. Herrick: Peculiar elongated and sickle-shaped red blood corpuscles in a case of severe anemia. In: Archives of Internal Medicine. Band 6, 1910, S. 517–521, PMC 2588723 (freier Volltext) – (Reprint).
K. Sun, Y. Xia: New insights into sickle cell disease: a disease of hypoxia. In: Current Opinion in Hematology. Band 20, Nummer 3, Mai 2013, S. 215–221. doi:10.1097/MOH.0b013e32835f55f9. PMID 23549375.
E. Sparkenbaugh, R. Pawlinski: Interplay between coagulation and vascular inflammation in sickle cell disease. In: British Journal of Haematology. Band 162, Nummer 1, Juli 2013, S. 3–14. doi:10.1111/bjh.12336. PMC 3878906 (freier Volltext).
B. E. Gee: Biologic complexity in sickle cell disease: implications for developing targeted therapeutics. In: TheScientificWorldJournal. 2013, S. 694146. doi:10.1155/2013/694146. PMC 3621302 (freier Volltext).
M. Y. Lim, K. I. Ataga, N. S. Key: Hemostatic abnormalities in sickle cell disease. In: Current Opinion in Hematology. Band 20, Nummer 5, September 2013, S. 472–477. doi:10.1097/MOH.0b013e328363442f. PMID 23817169.
ClinVar (Studienverzeichnis): NM_000518.5(HBB):c.20A>T (p.Glu7Val) AND HEMOGLOBIN S
J. I. Malowany, J. Butany: Pathology of sickle cell disease. In: Seminars in Diagnostic Pathology. Band 29, Nummer 1, Februar 2012, S. 49–55. PMID 22372205.
A. U. Orjih, R. Chevli, C. D. Fitch: Toxic heme in sickle cells: an explanation for death of malaria parasites. In: The American Journal of Tropical Medicine and Hygiene. Band 34, Nr. 2, März 1985, S. 223–227, PMID 3885769.
I. Akinsheye, A. Alsultan, N. Solovieff, D. Ngo, C. T. Baldwin, P. Sebastiani, D. H. Chui, M. H. Steinberg: Fetal hemoglobin in sickle cell anemia. In: Blood. Band 118, Nummer 1, Juli 2011, S. 19–27. doi:10.1182/blood-2011-03-325258. PMID 21490337. PMC 3139383 (freier Volltext).
O S Platt, S H Orkin, G Dover, G P Beardsley, B Miller: Hydroxyurea enhances fetal hemoglobin production in sickle cell anemia. In: Journal of Clinical Investigation. Band 74, Nr. 2, 1984, S. 652–656, doi:10.1172/JCI111464, PMC 370519 (freier Volltext).
Winfred C Wang, Russell E Ware, Scott T Miller, Rathi V Iyer, James F Casella: Hydroxycarbamide in very young children with sickle-cell anaemia: a multicentre, randomised, controlled trial (BABY HUG). In: The Lancet. Band 377, Nr. 9778, 14. Mai 2011, S. 1663–1672, doi:10.1016/S0140-6736(11)60355-3, PMC 3133619 (freier Volltext).

dailymed.nlm.nih.gov

OXBRYTA- voxelotor tablet, film coated. DailyMed, abgerufen am 7. November 2021 (englisch).

rki.de

2013 - 43 13.pdf. In: Epidemiologisches Bulletin. Abgerufen am 3. Februar 2014.

roteskreuz.at

Prof. R. Heinz: Transfusionsmedizin und Migration@1@2Vorlage:Toter Link/www.roteskreuz.at (Seite nicht mehr abrufbar, festgestellt im Mai 2024. Suche in Webarchiven)

scinexx.de

scinexx.de

spektrum.de

Kompaktlexikon Biologie, Spektrum Akademischer Verlag

web.archive.org

Skript der Harvard Medical School (Memento vom 27. November 2011 im Internet Archive) (englisch). Abgerufen am 5. April 2024.